NewsUp one level
Dr Silke Krol, PhD from the Fondazione IRCCS Neurologic Institute ‘Carlo Besta’ in Milan and ETP Nanomedicine member continues our nanomed series in the International Innovation magazine by highlighting the opportunities offered by nanotechnologies to fight diabetes.
Presentations and Webstreams of the Open Info Days on Challenge „Health, Demographic Change and Wellbeing“ available
The Open Info Days on Challenge „Health, Demographic Change and Wellbeing“ took place on 22.11.13 in Brussels.
6th Joint Call for European Research Projects on Rare Diseases (JTC 2014) (Innovative therapeutic approaches)
On the 5th of December 2013 E-Rare will officialy open its 6th Joint Transnational Call for Research Projects on Rare Diseases (JTC 2014). This year the call is specifically dedicated to development of innovative therapeutic approaches for rare diseases. The aim of the call is to enable scientists in different countries to build an effective collaboration on a common interdisciplinary research project based on complementarities and sharing of expertise, with a clear translational research approach
3rd Joint Transnational Call for Proposals of the ERA-NET on Translational Cancer Research to be launched in December 2013
The ERA-NET on Translational Cancer Research (TRANSCAN) has been established with the ultimate goal of coordinating the research efforts and funding programmes of European countries in translational cancer research. In this line, TRANSCAN will launch the third Joint Transnational Call for research proposals (JTC) in December 2013.
The European Commission made public these documents just before the adoption process of the work programmes to provide potential participants with the currently expected main lines of the work programmes 2014-2015. However, they are working documents not yet endorsed by the Commission and their contents does not in any way prejudge the final decision of the Commission.
"Five years from now every pharma will have a nano program". While there are 49 products on the market incorporating nanoparticles, there are four times that many now moving through the pipeline with half of those already in Phase II or Phase III trials. In his role as vice chair for the European Technology Platform on Nanomedicine, Laurent Levy described the state of the emerging field of nanotherapeutics to set the context for a special workshop at BIO-Europe® 2013 asking, ” Is nano becoming the next sweet spot for drug development?”
VALUE4NANO, a Coordinated Support Action funded by the European Commission to deliver recommendations for future program topics launched an online Value Chain Survey.
Two JPND Joint Transnational Calls aimed at supporting transnational collaborations in the field of neurodegenerative disease research will launch in early December 2013
EPoSS, the European Technology Platform on Smart Systems Integration organises on 10th December 2013 in Berlin a Proposers' Day, including a session with representatives from the European Commission and 3 brokerage sessions. Smart / Micro Systems in Health will definitely be a topic of the event.
Berlin, November 4th, 2013 – The winners of the first ever Nanomedicine Award were officially announced during the Nanomedicine Panel at BIO-Europe conference in Vienna, November 4th 2013. The Award review Board agreed to distinguish two projects: Endomagnetics technology in the nanodiagnostic category and I-CARE project from Linköping University in the regenerative medicine category.
The ETP Nanomedicine asked Dr. Varvara Karagkiozaki and Professor Stergios Logothetidis to continue the nanomed series started with the publication "International Innovation" by discussing the exciting headway being made in using nanomedicine to treat atherosclerosis.
On 29 October IMI launched its 10th Call for proposals. The deadline for submitting Expressions of Interestes (EoI) is 28 January 2014. The topic of this Call is Immunological assay standardisation and development for use in assessments of correlates of protection for influenza vaccines.
EuroNanoMed II, the European funding initiative under the ERA-NET scheme of the European Commission’s 7th Framework Programme, announced on the projects that will be funded following its 2013 joint transnational call for collaborative research projects.
Nanomedicine Award: winners of the best international nanomedicine innovation for 2013 to be officially announced during BIO-Europe® 2013
The Award to be presented in the Nanomedicine Panel at BIO-Europe conference in Vienna, November 2013 www.nanomedicine-award.com
The ETP Nanomedicine publishes regularly open positions or job offers from its members in a dedicated area of the website.
The ETPN Annual Event and General Assembly took place on 1st and 2nd October 2013 in Grenoble (France) and closed a very intensive but also very successful year, in which the ETPN marked a milestone towards the recognition of the field in the European context and in the EU Framework Programme for Research and Innovation.
The New York Academy of Sciences organises on 21st November 2013 in New York a conference to explore regulatory challenges in the nascent field of nanomedicines including the relevance and adequacy of existing frameworks, availability and expertise of regulators, and safety concerns.
The 5th International Congress BioNanoMed 2014 – Nanotechnology Enables Personalized Medicine will be held on 26 – 28 March 2014 at the International Meeting Centre Krems/Austria. The Call for Papers is now open till 17 December 2013.
Get the latest insights into the recent ETPN and NanoMed 2020 activities
The submission of Applications for the Nanomedicine AWARD 2013 is open till 7th September 2013!
Nanosafety in Europe 2015 - 2025, Towards Safe and Sustainable Nanomaterials and Nanotechnology Innovations
The Finnish Institute of Occupational Health, together with the members of the European Nanosafety Cluster have produced a research strategy for the European Commission.
A major novelty of the new EU Research and Innovation funding programme called Horizon 2020 is the introduction of a dedicated SME instrument, which builds on and learns from the success of the SBIR like instrument described above.
The Committee of Permanent Representatives endorsed on 17 July 2013 the agreement reached last June between the Presidency of the Council and the European Parliament representatives on the "Horizon 2020" programme for the years 2014 to 2020. The agreement paves the way for the formal adoption of the "Horizon 2020" legislative package by the European Parliament and the Council through a vote in the coming months.
France commits to a EUR 3.5 billion public-private partnership.
Continuing its collaboration with International Innovation, the ETPN Secretariat has started a Nanomed Series highlighting nanomedicine potential and applications for different diseases and current healthcare issues. The first one is dedicated to cancer and will be released as the last word of the August Issue of International Innovation.